Zymeworks authorizes $125 million share repurchase program

May 14, 2026 4:05 PM EDT Send to a Friend
Zymeworks Inc. (NASDAQ: ZYME) announced that its board of directors authorized a new share repurchase program allowing the company to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login